Tetraspanin CD151 regulates α6β1 integrin adhesion strengthening

  1. Jan Lammerding*,,
  2. Alexander R. Kazarov,,
  3. Hayden Huang§,
  4. Richard T. Lee*,§, and
  5. Martin E. Hemler,
  1. *Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, MA 02139; Dana-Farber Cancer Institute, Room D-1430, 44 Binney Street, Boston, MA 02115; and §Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115
  1. Edited by Thomas P. Stossel, Harvard Medical School, Boston, MA, and approved May 6, 2003 (received for review December 11, 2002)

Abstract

The tetraspanin CD151 molecule associates specifically with laminin-binding integrins, including α6β1. To probe strength of α6β1-dependent adhesion to laminin-1, defined forces (0–1.5 nN) were applied to magnetic laminin-coated microbeads bound to NIH 3T3 cells. For NIH 3T3 cells bearing wild-type CD151, adhesion strengthening was observed, as bead detachment became more difficult over time. In contrast, mutant CD151 (with the C-terminal region replaced) showed impaired adhesion strengthening. Static cell adhesion to laminin-1, and detachment of beads coated with fibronectin or anti-α6 antibody were all unaffected by CD151 mutation. Hence, CD151 plays a key role in selectively strengthening α6β1 integrin-mediated adhesion to laminin-1.

Footnotes

  • To whom correspondence should be addressed. E-mail: martin_hemler{at}dfci.harvard.edu.

  • J.L. and A.R.K. contributed equally to this work.

  • This paper was submitted directly (Track II) to the PNAS office.

« Previous | Next Article »Table of Contents